These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 30825248)

  • 41. Rational design and synthesis of 2,2-bisheterocycle tandem derivatives as non-nucleoside hepatitis B virus inhibitors.
    Chen HJ; Wang WL; Wang GF; Shi LP; Gu M; Ren YD; Hou LF; He PL; Zhu FH; Zhong XG; Tang W; Zuo JP; Nan FJ
    ChemMedChem; 2008 Sep; 3(9):1316-21. PubMed ID: 18663717
    [No Abstract]   [Full Text] [Related]  

  • 42. Synthesis, structure-activity relationships and biological evaluation of caudatin derivatives as novel anti-hepatitis B virus agents.
    Wang LJ; Geng CA; Ma YB; Huang XY; Luo J; Chen H; Guo RH; Zhang XM; Chen JJ
    Bioorg Med Chem; 2012 May; 20(9):2877-88. PubMed ID: 22472044
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Design, synthesis and biological evaluation of caudatin analogs as potent hepatitis B virus inhibitors.
    Wang LJ; Chen H; Ma YB; Huang XY; Geng CA; Zhang XM; Chen JJ
    Med Chem; 2015; 11(2):165-79. PubMed ID: 25181984
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Design, synthesis and biological evaluation of seco-A-pentacyclic triterpenoids-3,4-lactone as potent non-nucleoside HBV inhibitors.
    Li Z; Min Q; Huang H; Liu R; Zhu Y; Zhu Q
    Bioorg Med Chem Lett; 2018 May; 28(9):1501-1506. PubMed ID: 29627260
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synthesis and antiviral activity of new acrylamide derivatives containing 1,2,3-thiadiazole as inhibitors of hepatitis B virus replication.
    Dong WL; Liu ZX; Liu XH; Li ZM; Zhao WG
    Eur J Med Chem; 2010 May; 45(5):1919-26. PubMed ID: 20149495
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pyrimidotriazine derivatives as selective inhibitors of HBV capsid assembly.
    Toyama M; Sakakibara N; Takeda M; Okamoto M; Watashi K; Wakita T; Sugiyama M; Mizokami M; Ikeda M; Baba M
    Virus Res; 2019 Oct; 271():197677. PubMed ID: 31376401
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Heteroaryldihydropyrimidine (HAP) and Sulfamoylbenzamide (SBA) Inhibit Hepatitis B Virus Replication by Different Molecular Mechanisms.
    Zhou Z; Hu T; Zhou X; Wildum S; Garcia-Alcalde F; Xu Z; Wu D; Mao Y; Tian X; Zhou Y; Shen F; Zhang Z; Tang G; Najera I; Yang G; Shen HC; Young JA; Qin N
    Sci Rep; 2017 Feb; 7():42374. PubMed ID: 28205569
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antiviral activity of various 1-(2'-deoxy-β-D-lyxofuranosyl), 1-(2'-fluoro-β-D-xylofuranosyl), 1-(3'-fluoro-β-D-arabinofuranosyl), and 2'-fluoro-2',3'-didehydro-2',3'-dideoxyribose pyrimidine nucleoside analogues against duck hepatitis B virus (DHBV) and human hepatitis B virus (HBV) replication.
    Srivastav NC; Shakya N; Mak M; Agrawal B; Tyrrell DL; Kumar R
    J Med Chem; 2010 Oct; 53(19):7156-66. PubMed ID: 20857959
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Design, synthesis, and molecular hybrids of caudatin and cinnamic acids as novel anti-hepatitis B virus agents.
    Wang LJ; Geng CA; Ma YB; Luo J; Huang XY; Chen H; Zhou NJ; Zhang XM; Chen JJ
    Eur J Med Chem; 2012 Aug; 54():352-65. PubMed ID: 22687441
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Design, synthesis, and biological evaluation of novel 2'-deoxy-2'-fluoro-2'-C-methyl 8-azanebularine derivatives as potent anti-HBV agents.
    Yang W; Peng Y; Wang J; Song C; Yu W; Zhou Y; Jiang J; Wang Q; Wu J; Chang J
    Bioorg Med Chem Lett; 2019 Jun; 29(11):1291-1297. PubMed ID: 30962085
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Review of small synthetic molecules targeting HBV capsid assembly.
    Liu N; Zhao F; Zhan P; Liu X
    Med Chem; 2015; 11(8):710-6. PubMed ID: 25985859
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Resistance of hepatitis B virus to antiviral drugs: current aspects and directions for future investigation.
    Delaney WE; Locarnini S; Shaw T
    Antivir Chem Chemother; 2001 Jan; 12(1):1-35. PubMed ID: 11437320
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Anti-HBV agents. Part 1: Synthesis of alisol A derivatives: a new class of hepatitis B virus inhibitors.
    Zhang Q; Jiang ZY; Luo J; Cheng P; Ma YB; Zhang XM; Zhang FX; Zhou J; Chen JJ
    Bioorg Med Chem Lett; 2008 Aug; 18(16):4647-50. PubMed ID: 18644720
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Design and evaluation of hepatitis B virus inhibitors.
    Hantz O; Kraus JL; Zoulim F
    Curr Pharm Des; 2000 Mar; 6(5):503-23. PubMed ID: 10788594
    [TBL] [Abstract][Full Text] [Related]  

  • 55.
    Moianos D; Makri M; Prifti GM; Chiotellis A; Pappas A; Woodson ME; Tajwar R; Tavis JE; Zoidis G
    Molecules; 2024 Jun; 29(12):. PubMed ID: 38931006
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhibition of hepatitis B virus replication by drug-induced depletion of nucleocapsids.
    Deres K; Schröder CH; Paessens A; Goldmann S; Hacker HJ; Weber O; Krämer T; Niewöhner U; Pleiss U; Stoltefuss J; Graef E; Koletzki D; Masantschek RN; Reimann A; Jaeger R; Gross R; Beckermann B; Schlemmer KH; Haebich D; Rübsamen-Waigmann H
    Science; 2003 Feb; 299(5608):893-6. PubMed ID: 12574631
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Structure-activity relationships study of 6-chloro-4-(2-chlorophenyl)-3-(2-hydroxyethyl) quinolin-2(1H)-one derivatives as novel non-nucleoside anti-hepatitis B virus agents.
    Guo RH; Zhang Q; Ma YB; Luo J; Geng CA; Wang LJ; Zhang XM; Zhou J; Jiang ZY; Chen JJ
    Eur J Med Chem; 2011 Jan; 46(1):307-19. PubMed ID: 21145140
    [TBL] [Abstract][Full Text] [Related]  

  • 58. New targets and inhibitors of HBV replication to combat drug resistance.
    Cheng YC; Ying CX; Leung CH; Li Y
    J Clin Virol; 2005 Dec; 34 Suppl 1():S147-50. PubMed ID: 16461217
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Design, synthesis and anti-HBV activity study of novel HBV capsid assembly modulators.
    Liang M; Liu L; Liu J; Yang Z; Wang M; Xie Y; Cai Y; Xue P; Chen Y; Zhan P; Jia H
    Bioorg Med Chem Lett; 2024 Nov; 112():129913. PubMed ID: 39111727
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Phenylpropenamide derivatives as inhibitors of hepatitis B virus replication.
    Perni RB; Conway SC; Ladner SK; Zaifert K; Otto MJ; King RW
    Bioorg Med Chem Lett; 2000 Dec; 10(23):2687-90. PubMed ID: 11128652
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.